Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Paul Wotton Insider Profile
4 Followers
Paul Wotton, President and CEO, Director at Ocata Therapeutics, holds 1.75K shares in Vericel (Ticker: VCEL), holds 267.50K shares in Ocata Therapeutics (Ticker: OCAT), holds 937.73K shares in Antares Pharma (Ticker: ATRS).
Paul Wotton Ocata Therapeutics (OCAT)President and CEO, Director
Ocata Therapeutics (OCAT)
President and CEO, Director
Ranked #15,969 out of 78,624 Corporate Insiders
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+139.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Paul Wotton holds in companies
Most Profitable Insider Trade
The most profitable trade made by Paul Wotton
Paul Wotton's Trading History
Ocata Therapeutics
Feb 11, 2016
―
Uninformative Sell
2.36M
$2.27M
Vericel
May 01, 2020
Director
Uninformative Buy
―
$44.10K
Antares Pharma
Jun 02, 2014
President & CEO, Director
Uninformative Buy
―
$2.93M
List of latest transactions for each holding click on a transaction to see Paul Wotton's performance on stock
You May Also Like
Paul Wotton insider profile FAQ
What is the percentage of profitable transactions made by Paul Wotton?
The percentage of profitable transactions made by Paul Wotton is 100%.
What is the average return per transaction made by Paul Wotton?
The average return per transaction made by Paul Wotton is 139.80%.
What stocks does Paul Wotton hold?
Paul Wotton holds: OCAT, VCEL, ATRS stocks.
What was Paul Wotton’s latest transaction?
Paul Wotton latest transaction was an Uninformative Buy of ―.
What was Paul Wotton's most profitable transaction?
Paul Wotton’s most profitable transaction was an Informative Buy of ATRS stock on March 31, 2009. The return on the trade was 218.60%.
What is Paul Wotton's role in Ocata Therapeutics?
Paul Wotton's role in Ocata Therapeutics is President and CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.